Use of Metformin in Pediatric Age

    March 2011 in “ Pediatric diabetes ”
    Claudia Baratto, Danilo Fintini, Valério Nobili, Patrizia Ippolita Patera, Marco Cappa, M. Brufani
    Image of study
    TLDR Metformin helps manage diabetes, PCOS, and weight in kids but needs more research for long-term safety.
    The review article discussed the use of metformin in pediatric patients for conditions such as type 2 diabetes mellitus (T2DM), polycystic ovary syndrome (PCOS), obesity, and weight gain from atypical antipsychotic drugs. Metformin was effective in improving glycemic control in T2DM and T1DM, enhancing ovulation and reducing androgen levels in PCOS, and managing weight and adiposity in various pediatric conditions. However, its long-term efficacy and safety remained uncertain, necessitating further research with larger sample sizes and longer follow-up periods. Common side effects included gastrointestinal issues, but severe adverse events were rare. The only approved pediatric use at the time was for T2DM in adolescents, though the authors advocated for its approval in managing PCOS.
    Discuss this study in the Community →

    Research cited in this study

    4 / 4 results

    Related Community Posts Join

    6 / 44 results

    Similar Research

    5 / 1000+ results
      Type 2 Diabetes, Metabolic Syndrome, and Lipid Metabolism

      research Type 2 Diabetes, Metabolic Syndrome, and Lipid Metabolism

      January 2014 in “S. Karger AG eBooks”
      Type 2 diabetes in youth is increasing, with high treatment failure rates and more severe than Type 1; certain drugs can lower lipid levels effectively with varying side effects, and apples may benefit heart health like statins but with fewer side effects.
      Metformin and Amoxicillin/Clavulanate as Co-Administration for the Treatment of Hyperglycemia in Female Rats Caused by Alloxan

      research Metformin and Amoxicillin/Clavulanate as Co-Administration for the Treatment of Hyperglycemia in Female Rats Caused by Alloxan

      June 2025 in “Mağallaẗ ʻulūm al-rāfidayn”
      The study examined the effects of co-administering metformin and amoxicillin/clavulanate (AMC) on hyperglycemia in female rats with alloxan-induced diabetes. Involving 25 rats divided into five groups, the research found that the combination of AMC and metformin significantly reduced glucose levels compared to the diabetic control group, suggesting AMC enhances metformin's glucose-depletion effect. While sodium levels decreased significantly, there were no significant changes in triglycerides, total cholesterol, or electrolytes like chloride and potassium. The study highlights the potential benefits of this co-administration in managing hyperglycemia without affecting lipid profiles or electrolyte balance, though it notes limitations such as a small sample size and short duration.

      research Pancreatogenic Type 3C Diabetes

      7 citations , October 2018 in “Journal of Mind and Medical Sciences”
      Type 3C diabetes is a distinct condition needing more research and treatment strategies.